Stark SR - Search Results

1

Discriminatory Power of Combinatorial Antigen Recognition in Cancer T Cell Therapies.

Dannenfelser R, Allen GM, VanderSluis B, Koegel AK, Levinson S, Stark SR, Yao V, Tadych A, Troyanskaya OG, Lim WA. Dannenfelser R, et al. Among authors: stark sr. Cell Syst. 2020 Sep 23;11(3):215-228.e5. doi: 10.1016/j.cels.2020.08.002. Epub 2020 Sep 10. Cell Syst. 2020. PMID: 32916097 Free PMC article.

2

Synthetic cytokine circuits that drive T cells into immune-excluded tumors.

Allen GM, Frankel NW, Reddy NR, Bhargava HK, Yoshida MA, Stark SR, Purl M, Lee J, Yee JL, Yu W, Li AW, Garcia KC, El-Samad H, Roybal KT, Spitzer MH, Lim WA. Allen GM, et al. Among authors: stark sr. Science. 2022 Dec 16;378(6625):eaba1624. doi: 10.1126/science.aba1624. Epub 2022 Dec 16. Science. 2022. PMID: 36520915 Free PMC article.

3

The sole LSm complex in Cyanidioschyzon merolae associates with pre-mRNA splicing and mRNA degradation factors.

Reimer KA, Stark MR, Aguilar LC, Stark SR, Burke RD, Moore J, Fahlman RP, Yip CK, Kuroiwa H, Oeffinger M, Rader SD. Reimer KA, et al. Among authors: stark sr. RNA. 2017 Jun;23(6):952-967. doi: 10.1261/rna.058487.116. Epub 2017 Mar 21. RNA. 2017. PMID: 28325844 Free PMC article.

4

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.

Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A; LEADe Investigators. Feldman HH, et al. Neurology. 2010 Mar 23;74(12):956-64. doi: 10.1212/WNL.0b013e3181d6476a. Epub 2010 Mar 3. Neurology. 2010. PMID: 20200346 Clinical Trial.

5

The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.

Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H; LEADe investigators. Jones RW, et al. Alzheimers Dement. 2008 Mar;4(2):145-53. doi: 10.1016/j.jalz.2008.02.001. Alzheimers Dement. 2008. PMID: 18631958 Clinical Trial.

6

Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.

Brandes JL, Kudrow D, Stark SR, O'Carroll CP, Adelman JU, O'Donnell FJ, Alexander WJ, Spruill SE, Barrett PS, Lener SE. Brandes JL, et al. Among authors: stark sr. JAMA. 2007 Apr 4;297(13):1443-54. doi: 10.1001/jama.297.13.1443. JAMA. 2007. PMID: 17405970 Clinical Trial.

7

Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Silberstein SD, Stark SR, Lucas SM, Christie SN, Degryse RE, Turkel CC; BoNTA-039 Study Group. Silberstein SD, et al. Among authors: stark sr. Mayo Clin Proc. 2005 Sep;80(9):1126-37. doi: 10.4065/80.9.1126. Mayo Clin Proc. 2005. PMID: 16178492 Clinical Trial.

8

Sumatriptan and naproxen sodium for the acute treatment of migraine.

Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Smith TR, et al. Among authors: stark sr. Headache. 2005 Sep;45(8):983-91. doi: 10.1111/j.1526-4610.2005.05178.x. Headache. 2005. PMID: 16109111 Clinical Trial.

9

Transient dyskinesia and cerebral ischemia.

Stark SR. Stark SR. Neurology. 1985 Mar;35(3):445. doi: 10.1212/wnl.35.3.445. Neurology. 1985. PMID: 3974910 No abstract available.

10

Ocular dipping.

Stark SR, Masucci EF, Kurtzke JF. Stark SR, et al. Neurology. 1984 Mar;34(3):391-3. doi: 10.1212/wnl.34.3.391. Neurology. 1984. PMID: 6538285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page